Statera Biopharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Statera Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$3.35M, a 73.7% increase year-over-year.
  • Statera Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$91.8M, a 205% decline year-over-year.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$102M, a 742% decline from 2020.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$12.1M, a 357% decline from 2019.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$2.65M, a 26.7% increase from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$102M -$89.8M -742% Jan 1, 2021 Dec 31, 2021 10-K 2022-10-06
2020 -$12.1M -$9.45M -357% Jan 1, 2020 Dec 31, 2020 10-K 2022-10-06
2019 -$2.65M +$965K +26.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 -$3.61M Jan 1, 2018 Dec 31, 2018 10-K 2020-04-15
2013 -$17.3M +$971K +5.33% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-17
2012 -$18.2M -$14.2M -354% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-17
2011 -$4.01M +$22.4M +84.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$26.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.